PPT Slide
- Usual care: aspirin, clopidogrel,
heparin, nitrates, IIb/IIIa inhibitors,
beta-blockers, fibrinolytic therapy,
statins, ACE inhibitors, revascularization
- Short-term risk for recurrent events: 6.2% - 25%
- Opportunity: HDL Therapy targets unstable plaques
The Acute Coronary Syndrome (ACS) Patient